Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cells.

Wang G, Liu L, Sharma S, Liu H, Yang W, Sun X, Dong Q.

Biochem Biophys Res Commun. 2012 Aug 24;425(2):309-14. doi: 10.1016/j.bbrc.2012.07.087. Epub 2012 Jul 25.

PMID:
22842564
2.

HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression.

Dong Q, Sharma S, Liu H, Chen L, Gu B, Sun X, Wang G.

Toxicol Lett. 2014 Jan 3;224(1):121-9.

PMID:
24459703
3.

Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.

Jing Z, Gong L, Xie CY, Zhang L, Su HF, Deng X, Wu SX.

Radiother Oncol. 2009 Dec;93(3):468-73. doi: 10.1016/j.radonc.2009.08.008. Epub 2009 Sep 8.

PMID:
19744737
4.

HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression.

Dong Q, Sharma S, Liu H, Chen L, Gu B, Sun X, Wang G.

Toxicol Lett. 2013 Oct 25. pii: S0378-4274(13)01357-X. doi: 10.1016/j.toxlet.2013.10.014. [Epub ahead of print]

PMID:
24513429
5.

FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.

Su H, Jin X, Zhang X, Zhao L, Lin B, Li L, Fei Z, Shen L, Fang Y, Pan H, Xie C.

J Transl Med. 2015 Mar 31;13:104. doi: 10.1186/s12967-015-0464-6.

6.

Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.

Zhang H, Luo H, Jiang Z, Yue J, Hou Q, Xie R, Wu S.

J Radiat Res. 2016 Jul;57(4):370-80. doi: 10.1093/jrr/rrw030. Epub 2016 Apr 28.

7.

Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.

Su H, Jin X, Shen L, Fang Y, Fei Z, Zhang X, Xie C, Chen X.

Tumour Biol. 2016 Apr;37(4):5355-63. doi: 10.1007/s13277-015-4393-z. Epub 2015 Nov 11.

PMID:
26561473
8.

Identification of microRNAs involved in the radioresistance of esophageal cancer cells.

Su H, Jin X, Zhang X, Xue S, Deng X, Shen L, Fang Y, Xie C.

Cell Biol Int. 2014 Mar;38(3):318-25. doi: 10.1002/cbin.10202. Epub 2013 Nov 18.

PMID:
24155113
9.

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair.

Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X.

Onco Targets Ther. 2015 Feb 25;8:509-18. doi: 10.2147/OTT.S76958. eCollection 2015.

10.

Radiosensitization of esophageal carcinoma cells by the silencing of BMI-1.

Yang XX, Sang MX, Zhu SC, Liu ZK, Ma M.

Oncol Rep. 2016 Jun;35(6):3669-78. doi: 10.3892/or.2016.4744. Epub 2016 Apr 13.

PMID:
27108688
11.

Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Wang JL, Yu JP, Sun ZQ, Sun SP.

World J Gastroenterol. 2014 Dec 28;20(48):18296-305. doi: 10.3748/wjg.v20.i48.18296.

12.

[Expression profiles of microRNAs in radioresistant esophageal cell line].

Zheng ZF, Su HF, Zou Y, Peng Z, Wu SX.

Zhonghua Yi Xue Za Zhi. 2011 Mar 8;91(9):639-42. Chinese.

PMID:
21600139
13.

Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells.

Su H, Lin F, Deng X, Shen L, Fang Y, Fei Z, Zhao L, Zhang X, Pan H, Xie D, Jin X, Xie C.

J Transl Med. 2016 Jul 28;14(1):225. doi: 10.1186/s12967-016-0977-7.

14.

PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.

Park M, Yoon HJ, Kang MC, Kwon J, Lee HW.

Tumour Biol. 2016 Oct;37(10):14217-14224. Epub 2016 Aug 24.

PMID:
27557627
15.

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.

Zhang H, Yue J, Jiang Z, Zhou R, Xie R, Xu Y, Wu S.

Cell Death Dis. 2017 May 18;8(5):e2790. doi: 10.1038/cddis.2017.180.

16.

Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.

Zhang H, Luo H, Hu Z, Peng J, Jiang Z, Song T, Wu B, Yue J, Zhou R, Xie R, Chen T, Wu S.

Oncotarget. 2015 Mar 20;6(8):6218-34.

17.

WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice.

Li WF, Zhang L, Li HY, Zheng SS, Zhao L.

PLoS One. 2014 Apr 11;9(4):e94751. doi: 10.1371/journal.pone.0094751. eCollection 2014.

18.

Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells.

Fichter CD, Herz C, M√ľnch C, Opitz OG, Werner M, Lassmann S.

BMC Cell Biol. 2011 Apr 6;12:13. doi: 10.1186/1471-2121-12-13.

19.

XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.

Cheng J, Liu W, Zeng X, Zhang B, Guo Y, Qiu M, Jiang C, Wang H, Wu Z, Meng M, Zhuang H, Zhao L, Hao J, Cai Q, Xie D, Pang Q, Wang P, Yuan Z, Qian D.

Cancer Sci. 2015 Dec;106(12):1678-86. doi: 10.1111/cas.12820. Epub 2015 Nov 6.

20.

Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels.

Dong G, Chen Q, Jiang F, Yu D, Mao Q, Xia W, Shi R, Wang J, Xu L.

Oncotarget. 2016 Oct 18;7(42):68170-68178. doi: 10.18632/oncotarget.11906.

Supplemental Content

Support Center